SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-020982
Filing Date
2017-11-02
Accepted
2017-11-02 07:46:14
Documents
52
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q sage-10q_20170930.htm 10-Q 1881098
2 EX-10.1 sage-ex101_169.htm EX-10.1 12429
3 EX-31.1 sage-ex311_7.htm EX-31.1 9122
4 EX-31.2 sage-ex312_9.htm EX-31.2 9080
5 EX-32.1 sage-ex321_10.htm EX-32.1 10968
6 GRAPHIC g2017110119155784913943.jpg GRAPHIC 31618
  Complete submission text file 0001564590-17-020982.txt   5971631

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT sage-20170930.xml EX-101.INS 1343333
8 XBRL TAXONOMY EXTENSION SCHEMA sage-20170930.xsd EX-101.SCH 36150
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sage-20170930_cal.xml EX-101.CAL 37216
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sage-20170930_def.xml EX-101.DEF 113320
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE sage-20170930_lab.xml EX-101.LAB 272829
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sage-20170930_pre.xml EX-101.PRE 211268
Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Filer) CIK: 0001597553 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36544 | Film No.: 171170768
SIC: 2834 Pharmaceutical Preparations